| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.008 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.009 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |